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Extraskeletal Effects of  
Vitamin D Deficiency in Intensive 
Care Patients
Edward T. Zawada
Abstract
There has been a progression of investigations of the biology and pharmacology 
of vitamin D. Original work proved the importance of this axis on bone and skeletal 
homeostasis. Subsequent knowledge of basic cellular physiology led to studies of 
the role of vitamin D in other tissues where calcium flux is important to cellular 
functions. This was the beginning of exploration of vitamin D in extraskeletal 
health. Next came investigations into extraskeletal diseases which appeared to be 
more prevalent in vitamin D-deficient individuals. It was surprising that not only 
was there higher mortality from those diseases associated with low vitamin D 
levels, but also all-cause mortality was higher as well. Cellular pathophysiology of 
these findings was explored. Finally, studies have focused on outcomes in seriously 
ill patients with those diseases when hospitalized in the intensive care unit (ICU). 
Inverse correlations have been seen of several common ICU outcomes with levels 
of vitamin D at entry to the ICU, but the current effort is now in clarifying a role 
for routine measurement of these levels and the possible role of at least vitamin 
D replacement or even supplementation in the ICU patient with multiple organ 
pharmacologic or mechanical life support.
Keywords: vitamin D, extraskeletal, supplementation
1. Introduction
The important role of vitamin D in calcium homeostasis which in turn is so 
important to the cellular functions of diverse organs naturally led to interest in 
studying its role in extraskeletal health [1]. Calcium ions play an important role 
in signal transduction pathways where they act as a second messenger, in neu-
rotransmitter release from neurons, in contraction of all muscle cell types, and in 
fertilization. It was natural for studies to begin to explore the impact of vitamin 
D on vascular tone, cardiac contractility, neuron function, and hormone release 
and function. As mentioned in the introductory chapter, my observations led to 
further studies on the role of vitamin D and calcium on vascular tone, blood pres-
sure, and hypertensive states [2, 3]. It was not surprising when Framingham data 
and the National Health and Nutrition Examination Survey (NHANES 2001–2004) 
suggested that individuals with low levels of vitamin D were more likely to have a 
cardiovascular event, a higher prevalence of angina and myocardial infarction, and 
higher prevalence of heart failure and peripheral arterial disease [4, 5]. Reports of 
the consequences of vitamin D on mortality in a variety of serious illnesses and even 
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all-cause mortality were furthering this expanded role for vitamin D [5]. The pur-
pose of this chapter is to review the evidence for and against the impact of deficiency 
of vitamin D on the most seriously ill patients, those in the intensive care unit (ICU).
2. Extraskeletal dysfunction in vitamin D deficiency
A brief menu of organ dysfunction previously reported is now presented as a 
prelude to understanding possible contribution to prolonged recovery or higher 
mortality in seriously ill ICU patients [1].
a. Muscle weakness: some descriptive studies have associated muscle weakness 
with vitamin D deficiency. For example, vitamin D-deficient children have 
severe muscle weakness. However, randomized studies of supplementation 
have only led to some improvement in these series.
b. Falls due to musculoskeletal dysfunction has been reported to be associated 
with increased vitamin D-deficient elders with benefit of supplementation 
seen in many studies, especially in those patients with the lowest 25-hydroxy 
vitamin D levels, < 25 nmol/L.
c. Cancer incidence is associated with vitamin D deficiency for patients with 
colon cancer and breast cancer in postmenopausal women, but not prostate 
cancer. There are many small series of worsening outcomes in hematologic 
malignancies, especially in children, in vitamin D-deficient individuals, but 
supplementation has not been clearly shown to improve outcomes. Since many 
of these patients are admitted to the ICU for short-term management of emer-
gency complications of their diseases or treatments, surveillance of vitamin D 
may be important to the management of these patients. A very recent report 
on the subject of vitamin D supplementation and colorectal cancer will be 
presented in the Conclusion section of this chapter.
d. Immune system: vitamin D has effects on all cells of the immune system, and 
there are reports of deficiency associated with such immune-mediated diseases 
as diabetes, multiple sclerosis, and inflammatory bowel disease. Certainly in 
patients with these medical problems, complications develop requiring admis-
sion to the ICU. So it would seem that more studies and larger numbers of 
patients in these series are needed in the monitoring and at least maintenance 
of normal levels in patients with these common immune-mediated diseases.
e. Asthma: severe bronchospasm is a common reason for admission to the ICU, 
often in a younger or pediatric patient. The data on the role of vitamin D in 
this problem thus far is considered inconclusive. There has also been no good 
evidence of the need to aggressively search or supplement vitamin D in patients 
with chronic obstructive pulmonary disease (COPD).
f. Infection: despite the evidence for vitamin D on the immune system, no 
specific infections have required correction or supplementation with Vitamin 
D to improve success in the management of seriously ill patients.
g. CV system: in my introduction to this book, I review my previous work on 
the role of calcium and vitamin D in vascular tone and blood pressure [2, 3]. 
Despite these reports, no conclusive evidence has led to routine screening, 
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correction, or supplementation of vitamin D to prevent or control hyperten-
sion. In the Framingham Study [4], a relationship of vitamin D deficiency and 
risk of cardiovascular events was raised. This concern was furthered by data 
from the National Health and Nutrition Education Survey (NHANES) data [5].
h. Diabetes: as alluded previously there have been studies of increased incidence 
and severity of type 1 diabetes mellitus (T1DM) in vitamin D populations, 
but the evidence has not been conclusive. Diabetes is likely the most common 
comorbidity in intensive care unit patients.
i. Neuropsychiatry: despite the relationship of calcium and vitamin D to mem-
brane transport and neurohumoral secretion, the impact of vitamin D or its 
supplementation or augmentation on ICU neurologic diseases such as stroke or 
seizures has not been proven.
j. Pregnancy: there are reports of more complications with vitamin D-deficient 
mothers. No definitive studies suggest a role for monitoring or replacement or 
augmentation in ICU syndromes in pregnancy such as preeclampsia or hemoly-
sis, elevated liver enzymes, and low platelets (HELLP) syndrome.
3. Studies of vitamin D specific to patients in the ICU
There are multiple publications concerning vitamin D deficiency affecting 
mortality in seriously ill patients [6, 7]. Whereas these studies are prospective and 
controlled, the numbers of patients have not been great. In a report by Han et al. 
[7] high-dose vitamin D administration was studied in ventilated intensive care 
unit patients. This was a small pilot double-blinded randomized controlled trial. 
Twelve subjects were in each group. The levels were low in 43% of patients. The 
groups were given 50,000 vs. 1,000,000 units daily enterally vs. placebo for 5 days. 
High-dose vitamin D3 increased levels of 25OHD and led to decreased numbers 
of hospital days without any other improved clinical outcomes. The decrease in 
hospital length of stay not ICU days or ventilator days or hospital-acquired infec-
tions, hospital mortality, or mortality at day 84 was seen.
There are additional reports of the role of vitamin D in patients with specific major 
organ dysfunction. These reports have studied heart, lung, or kidney failure in the 
ICU. Those studies which have dealt with vitamin D supplements to assist with patients 
to be liberated from the ventilator because of respiratory failure have shown no benefit 
of supplementation to reduce time on the ventilator and speed liberation [7].
There are a considerable number of journal articles dealing with cardiac func-
tion in patients with disturbed calcium metabolism [8] and improvement of heart 
failure with vitamin D administration [9]. Renal failure is another common organ 
failure developing in seriously ill patient who requires often intensive care. There 
is a long tradition of vitamin D administration to dialysis patients due to their 
impaired renal activation of 25OH vitamin D to 1,25 dihydroxyvitamin D. New 
findings from a real-world study of 52,757 patients confirmed that vitamin D 
improves survival in hemodialysis patients [10].
4. Contradictory recent major studies
In the past few decades, there appeared to be a crescendo of possible multi-
system benefits from vitamin D supplementation reported throughout the world 
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medical literature. However, the crescendo has been halted by several recent 
negative studies. In a long-awaiting randomized, double-blinded, controlled trial, 
Manson studied vitamin D dosing of 2000 units of D3 daily in 25,000 adults with 
a mean age of 67 followed for a mean of 5.3 years [11]. He did not show difference 
in the occurrence of cardiovascular diseases or outcome of patients with invasive 
cancer or incidence of death from cancer, cardiovascular disease, or any cause 
which did not differ from those treated with placebo.
However, another recent prospective placebo-controlled report by Witte et al. 
[12] still suggests usefulness of vitamin D supplementation in patients with heart 
failure which likely contributes to morbidity in many if not most ICU patients. This 
is the vitamin D treating patients with chronic heart failure trial (VINDICATE). 
In this trial, there was no improvement in a 6-min walk but had beneficial effects 
on left ventricular structure and function in 229 patients with vitamin D levels 
<50 nmol/L or which is <20 ng/mL treated with 4000 units daily who had already 
been on contemporary optimal medical therapy for their heart failure with optimal 
medical therapy. Left ventricular structure was assessed by changes in stroke vol-
ume, and remodeling was assessed from improved left ventricular systolic diameter 
and end-diastolic diameter. One of the most recent issues of JAMA reported that 
high-dose vitamin D vs. standard-dose vitamin D when added to standard chemo-
therapy had no benefit for the outcome of median progression-free survival but did 
reduce the hazard ratio for progression or death. [13].
Just when the pendulum in the world’s literature seems to swing in one direction, 
new publications are reported for the opposite conclusions about vitamin D and 
extraskeletal health. The pendulum right now has swung against routine screening 
or supplementation in the treatment or prevention of extraskeletal organ dysfunc-
tion. But then Witte and the recent studies in dialysis patients suggest that the 
patients with heart and kidney dysfunction do benefit not only in organ function 
but also overall survival.
5. Conclusions and recommendations
There is some evidence that deficiency of vitamin D at the time of entry to 
the ICU is associated with worse outcomes. There are weak correlations between 
vitamin D levels and outcomes during the course of the ICU stay. Vitamin D is not 
recommended at this time to be routinely checked in ICU patients unless part of 
several large studies is ongoing worldwide such as the VINDICATE trial described 
above. Supplementation with vitamin D is routine in patients with renal failure 
and does improve outcomes in that group of patients commonly hospitalized in 
the ICU. There appears some benefit to supplementation of vitamin D in patients 
with heart failure, another group commonly hospitalized in the ICU. Studies are 
ongoing in this subgroup of patients. There appears no evidence for measurement 
or supplementation of vitamin D to patients with COPD exacerbations, asthma, 
and pneumonia or to assist with liberation from the ventilator. More large-scaled, 
multicenter, prospective, randomized, and controlled trials are needed. Dosing 
duration and correction of deficiency vs. creation of elevated levels by low- or high-
dose treatments are all variables which need systematic study.
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